Feorillo Galivo

1.5k citations

21 papers · 1.3k indexed · h-index 17

Co-authors: Jill Thompson Rosa María Díaz Richard G. Vile Timothy Kottke Phonphimon Wongthida Alan Melcher Glen N. Barber Kevin J. Harrington
Topics: Virus-based gene therapy research (15 papers)CAR-T cell therapy research (10 papers)Pancreatic function and diabetes (8 papers)
Cited by: Genetics Oncology Immunology
Journals: Nature Medicine Nature Biotechnology PLoS ONE
Partner nations: United States United Kingdom Thailand

In The Last Decade

Feorillo Galivo

21 papers receiving 1.3k citations

Peers

Countries citing papers authored by Feorillo Galivo

Since Specialization

Citations

This map shows the geographic impact of Feorillo Galivo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feorillo Galivo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feorillo Galivo more than expected).

Fields of papers citing papers by Feorillo Galivo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feorillo Galivo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feorillo Galivo. The network helps show where Feorillo Galivo may publish in the future.

Co-authorship network of co-authors of Feorillo Galivo

This figure shows the co-authorship network connecting the top 25 collaborators of Feorillo Galivo. A scholar is included among the top collaborators of Feorillo Galivo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feorillo Galivo. Feorillo Galivo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Beta Cell-Specific Expression Control Element for Recombinant Adeno-Associated Virus 2022 ·Human Gene Therapy ·Sunghee Chai,Young‐Jin Kim,Feorillo Galivo,Craig Dorrell,Leslie Wakefield,(unknown),Amanda M. Ackermann,Klaus H. Kaestner,Matthias Hebrok,Markus Grompe	3
2	Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors 2019 ·JCI Insight ·Katja Pekrun,Gustavo de Alencastro,(unknown),Jun Liu,Young‐Jin Kim,Sean Nygaard,Feorillo Galivo,Feijie Zhang,Song Ren,Matthew Tiffany,Jianpeng Xu,Matthias Hebrok,Markus Grompe,Mark A. Kay	73
3	Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts 2018 ·Molecular Therapy ·Yuhan Wang,Craig Dorrell,Willscott E. Naugler,(unknown),Paul T. Spellman,Bin Li,Feorillo Galivo,Annelise Haft,Leslie Wakefield,Markus Grompe	22
4	Reprogramming human gallbladder cells into insulin-producing β-like cells 2017 ·PLoS ONE ·Feorillo Galivo,Eric Benedetti,Yuhan Wang,Carl Pelz,Jonathan Schug,Klaus H. Kaestner,Markus Grompe	28
5	Is a β cell a β cell? 2017 ·Current Opinion in Endocrinology Diabetes and Obesity ·Chaoxing Yang,Feorillo Galivo,Craig Dorrell	3
6	Efficient generation of pancreatic β-like cells from the mouse gallbladder 2016 ·Stem Cell Research ·Yuhan Wang,Feorillo Galivo,Carl Pelz,Annelise Haft,Jonghyeob Lee,Seung K. Kim,Markus Grompe	10
7	Novel surface markers directed against adult human gallbladder 2015 ·Stem Cell Research ·Feorillo Galivo,Craig Dorrell,(unknown),(unknown),(unknown),Philip R. Streeter,Markus Grompe	6
8	Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming 2013 ·Stem Cell Research ·Raymond Hickey,Feorillo Galivo,Jonathan Schug,Michael A. Brehm,Annelise Haft,Yuhan Wang,Eric Benedetti,Guoqiang Gu,Mark A. Magnuson,Leonard D. Shultz,Eric Lagasse,Dale L. Greiner,Klaus H. Kaestner,Markus Grompe	37
9	Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma 2012 ·Nature Biotechnology ·José S. Pulido,Timothy Kottke,Jill Thompson,Feorillo Galivo,Phonphimon Wongthida,Rosa María Díaz,(unknown),Elizabeth J. Ilett,Larry R. Pease,Hardev Pandha,Kevin J. Harrington,Peter J. Selby,Alan Melcher,Richard G. Vile	86
10	Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors 2011 ·Nature Medicine ·Timothy Kottke,Fiona Errington‐Mais,José S. Pulido,Feorillo Galivo,Jill Thompson,Phonphimon Wongthida,Rosa María Díaz,Heung Chong,Elizabeth J. Ilett,John Chester,Hardev Pandha,Kevin J. Harrington,Peter J. Selby,Alan Melcher,Richard G. Vile	73
11	Activating Systemic T-Cell Immunity Against Self Tumor Antigens to Support Oncolytic Virotherapy with Vesicular Stomatitis Virus 2011 ·Human Gene Therapy ·Phonphimon Wongthida,Rosa María Díaz,(unknown),(unknown),Feorillo Galivo,Karen M. Kaluza,Timothy Kottke,Jill Thompson,Alan Melcher,Richard G. Vile	65
12	VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling 2010 ·Molecular Therapy ·Phonphimon Wongthida,Rosa María Díaz,Feorillo Galivo,Timothy Kottke,Jill Thompson,Alan Melcher,Richard G. Vile	55
13	Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide 2010 ·Molecular Therapy ·Candice Willmon,Rosa María Díaz,Phonphimon Wongthida,Feorillo Galivo,Timothy Kottke,Jill Thompson,Steven Μ. Albelda,Kevin J. Harrington,Alan Melcher,Richard G. Vile	28
14	Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer 2010 ·Cancer Research ·Phonphimon Wongthida,Rosa María Díaz,Feorillo Galivo,Timothy Kottke,Jill Thompson,José S. Pulido,Kevin D. Pavelko,Larry R. Pease,Alan Melcher,Richard G. Vile	89
15	Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma 2009 ·Gene Therapy ·Feorillo Galivo,Rosa María Díaz,Phonphimon Wongthida,Jill Thompson,Timothy Kottke,Glen N. Barber,Alan Melcher,R G Vile	63
16	Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus 2009 ·Human Gene Therapy ·Feorillo Galivo,Rosa María Díaz,Uma Thanarajasingam,Dragan Jevremović,Phonphimon Wongthida,Jill Thompson,Timothy Kottke,Glen N. Barber,Alan Melcher,Richard G. Vile	72
17	Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication 2009 ·Clinical Cancer Research ·Robin Prestwich,Elizabeth J. Ilett,Fiona Errington‐Mais,Rosa María Díaz,Lynette P. Steele,Tim Kottke,Jill Thompson,Feorillo Galivo,Kevin J. Harrington,Hardev Pandha,Peter J. Selby,Richard G. Vile,Alan Melcher	141
18	Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer 2008 ·Molecular Therapy ·Timothy Kottke,Rosa María Díaz,Karen M. Kaluza,José S. Pulido,Feorillo Galivo,Phonphimon Wongthida,Jill Thompson,Candice Willmon,Glen N. Barber,John Chester,Peter J. Selby,Scott E. Strome,Kevin J. Harrington,Alan Melcher,Richard G. Vile	40
19	Treg Depletion–enhanced IL-2 Treatment Facilitates Therapy of Established Tumors Using Systemically Delivered Oncolytic Virus 2008 ·Molecular Therapy ·Timothy Kottke,Feorillo Galivo,Phonphimon Wongthida,Rosa María Díaz,Jill Thompson,Dragan Jevremović,Glen N. Barber,Geoff Hall,John Chester,Peter J. Selby,Kevin J. Harrington,Alan Melcher,Richard G. Vile	46
20	Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy 2007 ·Nature Medicine ·Jian Qiao,Timothy Kottke,Candice Willmon,Feorillo Galivo,Phonphimon Wongthida,Rosa María Díaz,Jill Thompson,(unknown),Glen N. Barber,John Chester,Peter J. Selby,Kevin J. Harrington,Alan Melcher,Richard G. Vile	117

About Feorillo Galivo

Feorillo Galivo is a scholar working on Genetics, Oncology and Surgery, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (15 papers), CAR-T cell therapy research (10 papers) and Pancreatic function and diabetes (8 papers). The work is most often cited by research in Genetics (1.0k citations), Oncology (706 citations) and Immunology (396 citations). Feorillo Galivo has collaborated with scholars based in United States, United Kingdom and Thailand. Frequent co-authors include Jill Thompson, Rosa María Díaz, Richard G. Vile, Timothy Kottke, Phonphimon Wongthida, Alan Melcher, Glen N. Barber, Kevin J. Harrington, Peter J. Selby and Jian Qiao. Their work appears in journals such as Nature Medicine, Nature Biotechnology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact